Effect of Gb3 in lipid rafts in resistance to Shiga-like toxin of mutant Vero cells

Microbial Pathogenesis

Volumn 45, Issue 2, 2008, Pages 124-133

  Hanashima, Tatsuo ^a   Miyake, Masami ^a   Yahiro, Kinnosuke ^a   Iwamaru, Yoshifumi ^a   Ando, Akikazu ^a   Morinaga, Naoko ^a   Noda, Masatoshi ^a  

^a CHIBA UNIVERSITY   (Japan)

Author keywords

Gb3; Lipid rafts; Shiga like toxin

Indexed keywords

CERAMIDE DERIVATIVE; DETERGENT; GLOBOTRIACYLCERAMIDE; LIPID; MEMBRANE RECEPTOR; VEROTOXIN 1;

ANIMAL CELL; ARTICLE; BINDING ASSAY; CELL CLONE; CELL LYSATE; CELL MUTANT; CELL SIZE; CHEMICAL MUTAGENESIS; CONTROLLED STUDY; CYTOTOXICITY TEST; DENSITY; ENZYME LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI; HOST PATHOGEN INTERACTION; LIPID RAFT; NONHUMAN; PRIORITY JOURNAL; RECEPTOR BINDING; SURFACE PLASMON RESONANCE; THIN LAYER CHROMATOGRAPHY; VERO CELL; WILD TYPE;

ANIMALS; ANTIGENS, TUMOR-ASSOCIATED, CARBOHYDRATE; CERCOPITHECUS AETHIOPS; CHROMATOGRAPHY, THIN LAYER; ESCHERICHIA COLI; PROTEIN BINDING; RECEPTORS, CELL SURFACE; SHIGA TOXINS; TRIHEXOSYLCERAMIDES; VERO CELLS;

ESCHERICHIA COLI;

EID: 47049089016     PISSN: 08824010     EISSN: 10961208     Source Type: Journal    
DOI: 10.1016/j.micpath.2008.04.004     Document Type: Article

References (39)

1. Mainil J. Shiga/verocytotoxins and Shiga/verotoxigenic Escherichia coli in animals. Vet Res 30 (1999) 235-257
2. O'Brien A.D., and Holmes R.K. Shiga and Shiga-like toxins. Microbiol Rev 51 2 (1987) 206-220
3. O'Loughlin E.V., and Robins-Browne R.M. Effect of Shiga toxin and Shiga-like toxins on eukaryotic cells. Microbes Infect 3 (2001) 493-507
4. Jackson M.P., Neill R.J., O'Brien A.D., Holmes R.K., and Newland J.W. Nucleotide sequence analysis and comparison of the structural genes for Shiga-like toxin and Shiga-like toxin II encoded by bacteriophages from Escherichia coli 933. FEMS Microbiol Lett 44 (1987) 109-114
5. Donohue-Rolfe A., Acheson D.W., and Keusch G.T. Shiga toxin: purification, structure, and function. Rev Infect Dis 13 (1991) S293-S297
6. Head S.C., Karmali M.A., and Lingwood C.A. Preparation of VT1 and VT2 hybrid toxins from their purified dissociated subunits. Evidence for B subunit modulation of a subunit function. J Biol Chem 266 (1991) 3617-3621
7. Jacewicz M., Clausen H., Nudelman E., Donohue-Rolfe A., and Keusch G.T. Pathogenesis of shigella diarrhea. XI. Isolation of a shigella toxin-binding glycolipid from rabbit jejunum and HeLa cells and its identification as globotriaosylceramide. J Exp Med 163 (1986) 1391-1404
8. Lindberg A.A., Brown J.E., Stromberg N., Westling-Ryd M., Schultz J.E., and Karlsson K.A. Identification of the carbohydrate receptor for Shiga toxin produced by Shigella dysenteriae type 1. J Biol Chem 262 (1987) 1779-1785
9. Lingwood C.A., Law H., Richardson S., Petric M., Brunton J.L., De Grandis S., et al. Glycolipid binding of purified and recombinant Escherichia coli produced verotoxin in vitro. J Biol Chem 262 (1987) 8834-8839
10. Donta S.T., Tomicic T.K., and Donohue-Rolfe A. Inhibition of Shiga-like toxins by brefeldin A. J Infect Dis 171 (1995) 721-724
11. Sandvig K., Garred O., Prydz K., Kozlov J.V., Hansen S.H., and van Deurs B. Retrograde transport of endocytosed Shiga toxin to the endoplasmic reticulum. Nature 358 6386 (1992) 510-512
12. Sandvig K., Ryd M., Garred O., Schweda E., Holm P.K., and van Deurs B. Retrograde transport from the Golgi complex to the ER of both Shiga toxin and the nontoxic Shiga B-fragment is regulated by butyric acid and cAMP. J Cell Biol 126 (1994) 53-64
13. Sandvig K., and van Deurs B. Entry of ricin and Shiga toxin into cells: molecular mechanisms and medical perspectives. EMBO J 19 (2000) 5943-5950
14. Endo Y., Tsurugi K., Yutsudo T., Takeda Y., Ogasawara T., and Igarashi K. Site of action of a Vero toxin (VT2) from Escherichia coli O157:H7 and of Shiga toxin on eukaryotic ribosomes. RNA N-glycosidase activity of the toxins. Eur J Biochem 17 (1988) 45-50
15. Saxena S.K., O'Brien A.D., and Ackerman E.J. Shiga toxin, Shiga-like toxin II variant, and ricin are all single-site RNA N-glycosidases of 28 S RNA when microinjected into Xenopus oocytes. J Biol Chem 264 (1989) 596-601
16. Jacewicz M.S., Mobassaleh M., Gross S.K., Balasubramanian K.A., Daniel P.F., Raghavan S., et al. Pathogenesis of Shigella diarrhea: XVII. A mammalian cell membrane glycolipid, Gb3, is required but not sufficient to confer sensitivity to Shiga toxin. J Infect Dis 169 (1994) 538-546
17. Kiarash A., Boyd B., and Lingwood C.A. Glycosphingolipid receptor function is modified by fatty acid content. Verotoxin 1 and verotoxin 2c preferentially recognize different globotriaosyl ceramide fatty acid homologues. J Biol Chem 269 (1994) 11138-11146
18. Stein P.E., Boodhoo A., Tyrrell G.J., Brunton J.L., and Read R.J. Crystal structure of the cell-binding B oligomer of verotoxin-1 from E. coli. Nature 355 (1992) 748-750
19. Ling H., Boodhoo A., Hazes B., Cummings M.D., Armstrong G.D., Brunton J.L., et al. Structure of the shiga-like toxin I B-pentamer complexed with an analogue of its receptor Gb3. Biochemistry 37 (1998) 1777-1788
20. Soltyk A.M., MacKenzie C.R., Wolski V.M., Hirama T., Kitov P.I., Bundle D.R., et al. A mutational analysis of the globotriaosylceramide-binding sites of verotoxin VT1. J Biol Chem 277 (2002) 5351-5359
21. Brown D.A., and London E. Structure and function of sphingolipid- and cholesterol-rich membrane rafts. J Biol Chem 275 (2000) 17221-17224
22. Harder T., and Simons K. Caveolae, DIGs, and the dynamics of sphingolipid-cholesterol microdomains. Curr Opin Cell Biol 9 (1997) 534-542
23. Waheed A.A., Shimada Y., Heijnen H.F., Nakamura M., Inomata M., Hayashi M., et al. Selective binding of perfringolysin O derivative to cholesterol-rich membrane microdomains (rafts). Proc Natl Acad Sci U S A 98 (2001) 4926-4931
24. Schraw W., Li Y., McClain M.S., van der Goot F.G., and Cover T.L. Association of Helicobacter pylori vacuolating toxin (VacA) with lipid rafts. J Biol Chem 277 (2002) 34642-34650
25. Shogomori H., and Futerman A.H. Cholera toxin is found in detergent-insoluble rafts/domains at the cell surface of hippocampal neurons but is internalized via a raft-independent mechanism. J Biol Chem 276 (2001) 9182-9188
26. Wolf A.A., Fujinaga Y., and Lencer W.I. Uncoupling of the cholera toxin-G(M1) ganglioside receptor complex from endocytosis, retrograde Golgi trafficking, and downstream signal transduction by depletion of membrane cholesterol. J Biol Chem 277 (2002) 16249-16256
27. Katagiri Y.U., Mori T., Nakajima H., Katagiri C., Taguchi T., Takeda T., et al. Activation of Src family kinase yes induced by Shiga toxin binding to globotriaosyl ceramide (Gb3/CD77) in low density, detergent-insoluble microdomains. J Biol Chem 274 (1999) 35278-35282
28. Mori T., Kiyokawa N., Katagiri Y.U., Taguchi T., Suzuki T., Sekino T., et al. Globotriaosyl ceramide (CD77/Gb3) in the glycolipid-enriched membrane domain participates in B-cell receptor-mediated apoptosis by regulating Lyn kinase activity in human B cells. Exp Hematol 28 (2000) 1260-1268
29. Nakajima H., Kiyokawa N., Katagiri Y.U., Taguchi T., Suzuki T., Sekino T., et al. Kinetic analysis of binding between Shiga toxin and receptor glycolipid Gb3Cer by surface plasmon resonance. J Biol Chem 276 (2001) 42915-42922
30. Waddell T., Cohen A., and Lingwood C.A. Induction of verotoxin sensitivity in receptor-deficient cell lines using the receptor glycolipid globotriosylceramide. Proc Natl Acad Sci U S A 87 (1990) 7898-7901
31. Louise C.B., Kaye S.A., Boyd B., Lingwood C.A., and Obrig T.G. Shiga toxin-associated hemolytic uremic syndrome: effect of sodium butyrate on sensitivity of human umbilical vein endothelial cells to Shiga toxin. Infect Immun 63 (1995) 2766-2769
32. Kongmuang U., Honda T., and Miwatani T. Isolation of Shiga toxin-resistant Vero cells and their use for easy identification of the toxin. Infect Immun 56 (1988) 2491-2494
33. Pudymaitis A., Armstrong G., and Lingwood C.A. Verotoxin-resistant cell clones are deficient in the glycolipid globotriosylceramide: differential basis of phenotype. Arch Biochem Biophys 286 (1991) 448-452
34. Sekino T., Kiyokawa N., Taguchi T., Takenouchi H., Matsui J., Tang W.R., et al. Characterization of a Shiga-toxin 1-resistant stock of Vero cells. Microbiol Immunol 48 (2004) 377-387
35. Kurazono H., Sasakawa C., Yoshikawa M., and Takeda Y. Cloning of a Vero toxin (VT, Shiga-like toxin I) gene from a VT1-converting phage isolated from Escherichia coli O157:H7. FEMS Microbiol Lett 44 (1987) 23-26
36. Miyake M., Utsuno E., and Noda M. Binding of avian ovomucoid to shiga-like toxin type 1 and its utilization for receptor analog affinity chromatography. Anal Biochem 281 (2000) 202-208
37. Brown D.A., and Rose J.K. Sorting of GPI-anchored proteins to glycolipid-enriched membrane subdomains during transport to the apical cell surface. Cell 68 (1992) 533-544
38. Bligh E.G., and Dyer W.J. A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37 (1959) 911-917
39. Iwabuchi K., Yamamura S., Prinetti A., Handa K., and Hakomori S. GM3-enriched microdomain involved in cell adhesion and signal transduction through carbohydrate-carbohydrate interaction in mouse melanoma B16 cells. J Biol Chem 273 (10, 1998) 9130-9138